GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Receivables Turnover

Sumitomo Pharma Co (Sumitomo Pharma Co) Receivables Turnover : 0.89 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Sumitomo Pharma Co's Revenue for the three months ended in Mar. 2024 was $531 Mil. Sumitomo Pharma Co's average Accounts Receivable for the three months ended in Mar. 2024 was $598 Mil. Hence, Sumitomo Pharma Co's Receivables Turnover for the three months ended in Mar. 2024 was 0.89.

Sumitomo Pharma Co Receivables Turnover Historical Data

The historical data trend for Sumitomo Pharma Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Receivables Turnover Chart

Sumitomo Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.87 3.80 3.74 4.17 3.34

Sumitomo Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.77 0.79 0.89 0.89

Competitive Comparison of Sumitomo Pharma Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sumitomo Pharma Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Receivables Turnover falls into.


Sumitomo Pharma Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Sumitomo Pharma Co's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Receivables Turnover (A: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2024 ) / ((Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count )
=2099.592 / ((717.529 + 540.807) / 2 )
=2099.592 / 629.168
=3.34

Sumitomo Pharma Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

Receivables Turnover (Q: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2024 ) / ((Accounts Receivable (Q: Dec. 2023 ) + Accounts Receivable (Q: Mar. 2024 )) / count )
=530.842 / ((656.091 + 540.807) / 2 )
=530.842 / 598.449
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co  (OTCPK:DNPUF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Sumitomo Pharma Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Receivables Turnover
Comparable Companies
TSE:4540 TSE:4887 TSE:4547 TSE:4521 TSE:4534 TSE:4553 TSE:4569 TSE:4551 TSE:4559 TSE:4886 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
4506:Japan DPM:Germany
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
https://www.sumitomo-pharma.com
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.